Cohort study · 2004
Association of hemospermia with prostate cancer
Han M, Brannigan RE, Antenor JA, Roehl KA, Catalona WJ (2004). Association of hemospermia with prostate cancer. Journal of Urology. doi:10.1097/01.ju.0000144565.76243.b1
In a US prostate cancer screening study of 26,126 men mostly aged 50 or over, 0.5% reported blood in semen; prostate cancer was found in 13.7% of them versus 6.5% of all men screened.
Summary
Between 1991 and 2001, 26,126 men aged 50 or older (40 or older with a family history of prostate cancer or of Black race) took part in a community prostate cancer screening study using PSA blood tests and digital rectal examination. At entry, they answered a questionnaire that asked about hemospermia (blood in the semen).
Hemospermia was rare, reported by 139 men (0.5%), with a median age of 61. Prostate cancer was diagnosed in 19 of these 139 men (13.7%), compared with 1,708 of all 26,126 men screened (6.5%). After adjusting for age, PSA and rectal examination results, hemospermia remained a predictor of a prostate cancer diagnosis, although only at borderline statistical significance (odds ratio 1.73, p = 0.054). Of the 13 men with hemospermia who had their prostate removed, 10 had cancer confined to the prostate.
Limitations
The men were older and were being screened for prostate cancer, so the results do not apply to younger men. The number of men with hemospermia was small, and the adjusted result was at the edge of statistical significance.
What it means for you
In older men, blood in the semen deserves a prostate check, including a PSA test and an examination. It is not a reason to panic: most men with blood in their semen, even in this older group, did not have prostate cancer.